All stocks / PTIX
Protagenic Therapeutics, Inc.\new PTIX
Protagenic Therapeutics, Inc.\new (PTIX): a late 10-Q notice in August 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- PROTAGENIC THERAPEUTICS INC
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- Nov 16
- Website
- protagenic.com/
News headlines
The financial report, and what it means
Annual figures to 2026-03-31- Revenue
- $0
- Net income
- $1,367,977
It earned more than it spent
SteadyAfter all costs, the company kept $1.4 million as profit in the year.
- Cash and cash equivalents
- $1,509,178
- Net cash used in operating activities
- ($2,806,800)
The cash could run out soon
Under strainIt had $1.5 million in the bank and used about $233,900 a month. At that pace the money lasts about 6 months unless it borrows or sells more shares.
- Total assets
- $3,650,370
- Total liabilities
- $1,031,479
It owns more than it owes
SteadyEverything the company owns adds up to $3.7 million. Its debts and unpaid bills add up to $1 million. That is about $0.28 owed for every $1 owned.
What this adds up to
1 of 3 checks show strain. The cash could run out soon. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 1,736,675 shares as of 2026-11-06: 1,810,208 outstanding minus 73,533 held by 1 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Filed NT 10-Q on 2026-08-14: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Filed NT 10-K on 2026-06-30: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Filed NT 10-Q on 2026-02-18: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about PTIX
Does PTIX file reports with the SEC?
Yes. Protagenic Therapeutics, Inc.\new files with the SEC under company number 0001022899. The most recent filing we hold is a 8-K dated 2026-11-06.
Source recordHow many PTIX shares are outstanding?
1,810,208 shares as of 2026-11-06, as reported to the SEC.
Source recordHas PTIX filed reports late?
Yes. In the last 12 months it filed 3 late-filing notices, most recently a NT 10-Q on 2026-08-14. A notice means a report was not ready on time; check whether the report followed.
Source recordWho runs Protagenic Therapeutics, Inc.\new?
Officers named in its insider filings: Garo H Armen (EXEC. CHAIR & PRINCIPAL OFF).
Source recordIs Protagenic Therapeutics, Inc.\new making money?
After all costs, the company kept $1.4 million as profit in the year. (Annual figures to 2026-03-31. Facts from the company's own report, not a recommendation.)
Source record